What is Orthofix Medical Inc.'s R&D?

Orthofix Medical Inc. (OFIX) reported R&D of $15.32M in Q1 2026.

How has Orthofix Medical Inc.'s R&D changed year-over-year?

Orthofix Medical Inc.'s R&D decreased by 22.5% year-over-year, from $19.77M to $15.32M.

What is the long-term trend for Orthofix Medical Inc.'s R&D?

Over 4 years (2021 to 2025), Orthofix Medical Inc.'s R&D has grown at a 7.3% compound annual growth rate (CAGR), from $49.62M to $65.85M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Orthofix Medical Inc. OFIX R&D

R&D at other companies

StrykerSYK

$413M+2.0%

Alphatec HoldingsATEC

$17.56M+5.9%

EnovisENOV

$31.53M+10.5%

OrthoPediatricsKIDS

$2.23M-5.1%

MedtronicMDT

$671M-1.9%

BioventusBVS

$2.47M-18.1%

Other financials

Income statement

See full

Revenue$196.7M+1.6%

Gross profit$139.5M+14.7%

Operating income-$14.4M+70.5%

Net income-$20.9M+60.6%

EPS (diluted)-$0.52+61.5%

Balance sheet

See full

Cash & equivalents$120.3M+108%

Total debt$237.5M+32.3%

Total equity$435.2M-5.0%

Total assets$886.6M+7.7%

Cash flow

See full

Operating cash flow-$17.6M+4.2%

CapEx$10.7M+58.3%

Free cash flow-$28.3M-12.5%

Valuation

See full

Market cap$376.33M-7.1%

Enterprise value$493.54M-6.3%

P/S0.5×0.0×

Profitability

See full

Gross margin70.7%+3.6pp

Operating margin-5.8%-2.1pp

Net margin-7.3%-2.7pp

FCF margin-9.3%-1.7pp

Returns & leverage

See full

Return on equity-13.4%-4.6pp

Debt / equity0.5×+0.2×

Current ratio2.9×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Orthofix Medical Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Orthofix Medical Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Orthofix Medical Inc.'s R&D?: Orthofix Medical Inc. (OFIX) reported R&D of $15.32M in Q1 2026.
How has Orthofix Medical Inc.'s R&D changed year-over-year?: Orthofix Medical Inc.'s R&D decreased by 22.5% year-over-year, from $19.77M to $15.32M.
What is the long-term trend for Orthofix Medical Inc.'s R&D?: Over 4 years (2021 to 2025), Orthofix Medical Inc.'s R&D has grown at a 7.3% compound annual growth rate (CAGR), from $49.62M to $65.85M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.